Avedro’s Eye Drug-Device Combo Haunted By Past Sponsor’s Decisions
This article was originally published in The Gray Sheet
Executive Summary
FDA device and drug advisory panels will weigh clinical trial design, low study enrollment and device changes in review of Avedro's application for two orphan eye conditions.